Botulinum neurotoxins in the treatment of refractory pain (original) (raw)
Jankovic J et al. (2008) Botulinum Toxin: Therapeutic Clinical Practice and Science. New York: Saunders/Elsevier Google Scholar
Singh BR (2002) Molecular basis of the unique endopeptidase activity of botulinum neurotoxin. In Scientific and Therapeutic Aspects of Botulinum Toxin, 75–88 (Eds Brin M0 et al.) Philadelphia: Lippincott Williams and Willkins Google Scholar
Brin MF et al. (2008) Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Mov Disord23: 1353–1360 Article Google Scholar
Meng J et al. (2007) Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J Cell Sci120: 2864–2874 ArticleCAS Google Scholar
Lucioni A et al. (2008) Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int101: 366–370 ArticleCAS Google Scholar
Aoki KR (2003) Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache43 (Suppl 1): S9–S15 Article Google Scholar
Filippi GM et al. (1993) Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolarynol113: 400–404 ArticleCAS Google Scholar
Cui M et al. (2004) Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain107: 125–133 ArticleCAS Google Scholar
Chuang YC et al. (2008) Intraprostatic botulinum toxin A injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. J Urol180: 742–748 ArticleCAS Google Scholar
Namazi H (2008) Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis: a molecular mechanism. Urology72: 463–464 Article Google Scholar
Rand MJ and Whaler BC (1965) Impairment of sympathetic transmission by botulinum toxin. Nature206: 588–591 ArticleCAS Google Scholar
Chaddock JA et al. (2004) Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain. Mov Disord19 (Suppl 8): S42–S47 Article Google Scholar
Comella CL (2008) The treatment of cervical dystonia with botulinum toxins. J Neural Transm115: 579–583 ArticleCAS Google Scholar
Greene P et al. (1990) Double-blind, placebo controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology40: 1213–1218 ArticleCAS Google Scholar
Poewe W et al. (1998) What is the optimum dose of botulinum toxin A in the treatment of cervical dystonia? Result of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry64: 13–17 ArticleCAS Google Scholar
Troung D et al. (2005) Efficacy and safety of botulinum A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord20: 783–791 Article Google Scholar
Lew MF et al. (1997) Botulinum toxin type B: a double-blind, placebo-controlled safety and efficacy study in cervical dystonia. Neurology49: 701–707 ArticleCAS Google Scholar
Brin MF et al. (1999) Safety and efficacy of Neurobloc (botulinum toxin type B) in type-A resistant cervical dystonia. Neurology53: 1431–1438 ArticleCAS Google Scholar
Brashear A et al. (1999) Safety and efficacy of Neurobloc (botulinum toxin type B) in type-A resistant cervical dystonia. Neurology53: 1439–1446 ArticleCAS Google Scholar
Brans JW et al. (1996) Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind trial. Neurology46: 1066–1072 ArticleCAS Google Scholar
Comella CL et al. (2005) Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology65: 1423–1429 ArticleCAS Google Scholar
Pappert EJ and Germanson T (2008) Botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: randomized, double-blind, non-inferiority trial. Mov Disord23: 510–517 Article Google Scholar
Benecke R et al. (2005) A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology64: 1949–1951 ArticleCAS Google Scholar
Odergren T et al. (1998) A double blind, randomized, parallel group study to investigate the dose equivalance of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry64: 6–12 ArticleCAS Google Scholar
Poewe W et al. (1992) Treatment of spasmodic torticollis with local injections of botulinum toxin. One year follow up in 37 patients. J Neurol239: 21–25 ArticleCAS Google Scholar
Kessler KR et al. (1999) Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety and antibody frequency. German Dystonia Study group. J Neurol246: 265–274 ArticleCAS Google Scholar
Simpson DM et al. (2008) Assessment: botulinum toxin for treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology70: 1699–1706 ArticleCAS Google Scholar
Lipton RB and Silberstein SD (2001) The role of headache-related disability in migraine management: implications for headache treatment guidelines. Neurology56 (6 Suppl 1): S35–S42 ArticleCAS Google Scholar
Saper JR et al. (2007) A double-blind, randomized, placebo-controlled comparison of botulinum toxin type A injection sites and doses in the prevention of episodic migraine. Pain Med8: 478–485 Article Google Scholar
Elkind AH et al. (2006) A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis. Pain7: 688–696 ArticleCAS Google Scholar
Aurora SK et al. (2007) Botulinum toxin type A prophylactic treatment of episodic migraine: a randomized double blind, placebo-controlled exploratory study. Headache47: 486–499 Article Google Scholar
Relja M et al. (2007) A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches. Cephalalgia27: 492–503 ArticleCAS Google Scholar
Silberstein S et al. (2000) Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache40: 445–450 ArticleCAS Google Scholar
Evers S et al. (2004) Botulinum toxin A in the prophylactic treatment of migraine—a randomized, double-blind, placebo-controlled study. Cephalalgia24: 838–843 ArticleCAS Google Scholar
Vo AH et al. (2007) Botulinum toxin type-A in the prevention of migraine: a double-blind controlled trial. Aviat Space Environ Med78 (5 Suppl): B113–B118 PubMed Google Scholar
Blumenfeld AM et al. (2008) Botulinum toxin A and divalproex sodium for prophylactic treatment of episodic or chronic migraine. Headache48: 210–220 Article Google Scholar
Schulte-Mattler WJ and Leinisch E (2008) Evidence based medicine on the use of botulinum toxin for headache disorders. J Neural Transm115: 647–651 ArticleCAS Google Scholar
Freitag FG et al. (2008) Botulinum toxin type A in the treatment of chronic migraine without medication overuse. Headache48: 201–209 PubMed Google Scholar
Ondo WG et al. (2004) Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study. Cephalalgia24: 60–65 ArticleCAS Google Scholar
Mathew NT et al. (2005) Botulinum toxin type A (Botox) for the prophylactic treatment of chronic daily headache: a randomized double-blind, placebo-controlled trial. Headache45: 293–307 Article Google Scholar
Dodick DW et al. (2005) Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache45: 315–324 Article Google Scholar
Silberstein SD et al. (2005) Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double blind, placebo controlled trial. Mayo Clin Proc80: 1126–1137 ArticleCAS Google Scholar
Naumann M et al. (2008) Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review). Neurology70: 1707–1714 ArticleCAS Google Scholar
Ashkenazi A and Silberstein S (2008) Botulinum toxin type A for the treatment of headache: why we say yes. Arch Neurol65: 146–149 Article Google Scholar
Rollnik JD et al. (2000) Treatment of tension-type headache with botulinum toxin A: a double-blind, placebo-controlled study. Headache40: 300–305 ArticleCAS Google Scholar
Schmitt WJ et al. (2001) Effect of botulinum toxin A injections in the treatment of tension-type headaches: a double-blind, placebo-controlled trial. Headache41: 658–664 ArticleCAS Google Scholar
Padberg M et al. (2004) Treatment of tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia24: 675–680 ArticleCAS Google Scholar
Schulte-Mattler WJ and Krack P (2004) Treatment of chronic tension-type headache with botulinum toxin A. A randomized, double blind, placebo-controlled multi-center study. Pain109: 110–114 ArticleCAS Google Scholar
Silberstein SD et al. (2006) Botulinum toxin type A in the prophylactic treatment of tension-type headache: a multi-center, double blind, randomized, placebo-controlled, parallel-group study. Cephalalgia26: 790–800 ArticleCAS Google Scholar
Straube A et al. (2008) Pericranial injection of botulinum toxin type A (Dysport) for tension-type headache—a multicentre, double-blind, randomized, placebo-controlled study. Eur J Neurol15: 205–213 ArticleCAS Google Scholar
Freund BJ and Schwartz M (2000) Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study. J Rheumatol27: 481–484 CASPubMed Google Scholar
Wheeler AH et al. (1998) A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine23: 1662–1666 ArticleCAS Google Scholar
Ferrante FM et al. (2005) Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type. Anesthesiology103: 377–383 ArticleCAS Google Scholar
Ojala T et al. (2006) The effects of small doses of botulinum toxin A on neck–shoulder myofascial pain syndrome. A double-blind, randomized, and controlled crossover trial. Clin J Pain22: 90–96 Article Google Scholar
Göbel H et al. (2006) Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Pain125: 82–88 Article Google Scholar
Qerama E et al. (2006) A double-blind, controlled study of botulinum toxin A in chronic myofascial pain. Neurology67: 241–245 ArticleCAS Google Scholar
Lew HL et al. (2008) Therapeutic doses of botulinum toxin A in treating neck and upper back pain of myofascial origin: a pilot study. Arch Phys Med Rehabil89: 75–80 Article Google Scholar
Foster L et al. (2001) Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology56: 1290–1293 ArticleCAS Google Scholar
Jabbari B et al. (2006) Treatment of refractory, chronic low back pain with botulinum neurotoxin A: an open-label, pilot study. Pain Med7: 260–264 Article Google Scholar
Childers MK et al. (2002) Botulinum toxin type A use in piriformis muscle syndrome: a pilot study. Am J Phys Med Rehabil81: 751–759 Article Google Scholar
Fishman LM et al. (2002) BOTOX and physical therapy in the treatment of piriformis syndrome. Am J Phys Med Rehabil81: 936–942 Article Google Scholar
Babcock MS et al. (2005) Treatment of pain attributed to plantar fasciitis with botulinum toxin a: a short-term, randomized, placebo-controlled, double-blind study. Am J Phys Med Rehabil84: 649–654 Article Google Scholar
Prather H et al. (2007) Recognizing and treating pelvic pain and pelvic floor dysfunction. Phys Med Rehabil Clin N Am18: 477–496 Article Google Scholar
Abbott JA et al. (2006) Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol108: 915–923 Article Google Scholar
Argoff CE (2002) A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain18 (6 Suppl): S177–S181 Article Google Scholar
Ranoux D et al. (2008) Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol64: 274–283 Article Google Scholar
Barwood S et al. (2000) Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neurol42: 116–121 ArticleCAS Google Scholar
Layeeque R et al. (2004) Botulinum toxin infiltration for pain control after mastectomy and expander reconstruction. Ann Surg240: 608–613 PubMedPubMed Central Google Scholar
Davies J et al. (2003) Botulinum toxin (Botox) reduces pain after hemorrhoidectomy: results of a double-blind, randomized study. Dis Colon Rectum46: 1097–1102 Article Google Scholar